Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Coherent/IFS

This article was originally published in The Gray Sheet

Executive Summary

Coherent acquires 37% stake in privately held Silver Spring, Maryland-based Infrared Fiber Systems. Under terms of the deal, which includes the purchase by Coherent and IFS of most of Westinghouse Electric Corp.'s common stock in IFS, Coherent gains "certain exclusive distribution rights" to IFS fibers for erbium lasers, Coherent states in a Feb. 15 release. Clinical studies using Coherent erbium lasers and IFS fibers currently are under way. "Promising opportunities include a wide range of ophthalmic microsurgical applications, delicate dissection of brain and nerve tissue, bone sculpting in middle ear surgery as well as higher power dental and orthopedic applications," Coherent says

Latest Headlines
See All
UsernamePublicRestriction

Register

MT001895

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel